Email Updates

You are here

Home

BCPP

Status
Completed
Phase
IV
Principal Investigator(s)
Myron Essex, Victor DeGruttola, Refeletswe Lebelonyane & Shanaaz El Halabi
Objective


Designed to test the hypothesis that implementing an enhanced combination prevention package which includes provision of ART as prevention for HIV-infected individuals will impact the HIV/AIDS epidemic by significantly reducing population-level, cumulative HIV incidence in a defined geographic area over a period of 3 years and will be cost-effective.

Last updated September 8, 2022

Prevention Option(s)
Treatment
Study Design
Controlled
Randomized
Arms and Assigned Interventions
Description
Combination prevention
ARMs
Experimental
Description
Enhanced care
ARMs
Placebo Comparator
Results
Finding, treating and retaining persons with HIV in a high HIV prevalence and high treatment coverage country: Results from the Botswana Combination Prevention Project
Official Code
NCT01965470
Related Publications
Health Impact and Cost-Effectiveness of HIV Testing, Linkage, and Early Antiretroviral Treatment in the Botswana Combination Prevention Project
To achieve 95-95-95 targets we must reach men and youth: High level of knowledge of HIV status, ART coverage, and viral suppression in the Botswana Combination Prevention Project through universal te
Self-reported risky sexual practices among adolescents and young adults in Botswana
Trial Sponsors
CDC, Botswana-Harvard AIDS Institute Partnership, Botswana Ministry of Health, Harvard School of Public Health, Tebelopele.
October 2013
July 2018
16
Years
64
Years
Population
HIV positive
Men
Women
Sites

Site(s) - Botswana

Botswana